{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:04:49Z","timestamp":1793196289437,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1245\/s10434-014-3725-3","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T19:25:38Z","timestamp":1398281138000},"page":"2956-2962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum"],"prefix":"10.1245","volume":"21","author":[{"given":"James D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinru","family":"Shia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"issue":"1","key":"3725_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","volume":"122","author":"GJ Gardner","year":"2011","unstructured":"Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190\u20138.","journal-title":"Gynecol Oncol."},{"key":"3725_CR2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","volume":"68","author":"C Moertel","year":"1991","unstructured":"Moertel C, et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227\u201332.","journal-title":"Cancer."},{"issue":"4","key":"3725_CR3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ecl.2010.08.009","volume":"39","author":"G Rindi","year":"2010","unstructured":"Rindi G, Inzani F, Solcia E. Pathology of gastrointestinal disorders. Endocrinol Metab Clin N Am. 2010;39(4):713\u201327.","journal-title":"Endocrinol Metab Clin N Am."},{"issue":"6","key":"3725_CR4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","volume":"39","author":"JR Strosberg","year":"2010","unstructured":"Strosberg JR, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39(6):799\u2013800.","journal-title":"Pancreas."},{"issue":"18S","key":"3725_CR5","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1200\/jco.2007.25.18_suppl.15038","volume":"25","author":"C Ferrone","year":"2007","unstructured":"Ferrone C, Tang L, Tomplinson J, et al. Pancreatic neuroendocrine tumors: can the WHO staging system be simplified. J Clin Oncol. 2007;25(18S):15038.","journal-title":"J Clin Oncol."},{"key":"3725_CR6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1053\/hupa.2002.129204","volume":"33","author":"S Eeden Van","year":"2002","unstructured":"Van Eeden S, Quadvlieg P, Babs G, et al. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol. 2002;33:1126\u201332.","journal-title":"Hum Pathol."},{"issue":"22","key":"3725_CR7","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","volume":"29","author":"JR Strosberg","year":"2011","unstructured":"Strosberg JR, et al. Prognostic validity of a novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29(22):3044\u20139.","journal-title":"J Clin Oncol."},{"key":"3725_CR8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","volume":"451","author":"G Rindi","year":"2007","unstructured":"Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757\u201362.","journal-title":"Virchows Arch."},{"key":"3725_CR9","doi-asserted-by":"crossref","unstructured":"Sorbye W, Welin S, Langer S, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: the NORDIC NEC study [abstract number 4015]. J Clin Oncol. 2012;30(15S):4015.","DOI":"10.1200\/jco.2012.30.15_suppl.4015"},{"issue":"2","key":"3725_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10350-003-0038-1","volume":"47","author":"PE Bernick","year":"2004","unstructured":"Bernick PE, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47(2):163\u20139.","journal-title":"Dis Colon Rectum."},{"issue":"6","key":"3725_CR11","first-page":"1080","volume":"104","author":"ED Staren","year":"1988","unstructured":"Staren ED, et al. Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery. 1988;104(6):1080\u20139.","journal-title":"Surgery"},{"issue":"8","key":"3725_CR12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","volume":"81","author":"E Mitry","year":"1999","unstructured":"Mitry E, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer. 1999;81(8):1351\u20135.","journal-title":"Br J Cancer."},{"issue":"22","key":"3725_CR13","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1200\/JCO.2005.05.0575","volume":"24","author":"JD Hainsworth","year":"2006","unstructured":"Hainsworth JD, et al. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. J Clin Oncol. 2006;24(22):3548\u201354.","journal-title":"J Clin Oncol."},{"issue":"9","key":"3725_CR14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.humpath.2009.01.010","volume":"40","author":"J Strosberg","year":"2009","unstructured":"Strosberg J, et al. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors. Hum Pathol. 2009;40(9):1262\u20138.","journal-title":"Hum Pathol."},{"issue":"5","key":"3725_CR15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0b013e318159371c","volume":"32","author":"J Shia","year":"2008","unstructured":"Shia J, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol. 2008;32(5):719\u201331.","journal-title":"Am J Surg Pathol."},{"issue":"9","key":"3725_CR16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.bjc.6601758","volume":"90","author":"B Brenner","year":"2004","unstructured":"Brenner B, et al. Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer. 2004;90(9):1720\u20136.","journal-title":"Br J Cancer."},{"key":"3725_CR17","doi-asserted-by":"crossref","unstructured":"Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009;20(Suppl 4):54\u20136.","DOI":"10.1093\/annonc\/mdp128"},{"key":"3725_CR18","doi-asserted-by":"crossref","unstructured":"Van Cutsem E, Oliveira J. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann. Oncol. 2009;20(Suppl 4):49\u201350.","DOI":"10.1093\/annonc\/mdp126"},{"key":"3725_CR19","doi-asserted-by":"crossref","unstructured":"Sorensen M, Felip E. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 2009;20(Suppl 4):71\u20132.","DOI":"10.1093\/annonc\/mdp133"},{"key":"3725_CR20","doi-asserted-by":"crossref","unstructured":"Poultsides GA, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J. Clin. Oncol. 2009;27(20):3379\u201384.","DOI":"10.1200\/JCO.2008.20.9817"},{"key":"3725_CR21","unstructured":"Schneider BJ, Saxena A, Downey RJ. Surgery for early-stage small cell lung cancer. J. Natl. Compr. Canc. Netw. 2011;9(10):1132\u20139."},{"key":"3725_CR22","unstructured":"Okita NT, et al. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma. Gastric. Cancer. 2011;14(2):161\u20135."},{"key":"3725_CR23","unstructured":"Iwasa S, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn. J. Clin. Oncol. 2010;40(4):313\u20138."},{"key":"3725_CR24","doi-asserted-by":"crossref","unstructured":"Welin S, et al. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Cancer. 2011;117(20):4617\u201322.","DOI":"10.1002\/cncr.26124"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3725-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3725-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3725-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T04:37:38Z","timestamp":1597725458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3725-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["3725"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3725-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}